Stock In Focus – TAM Stock Screener – Co-Diagnostics Inc (NASDAQ: CODX)

Johnny HopkinsStock ScreenerLeave a Comment

As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.

One of the cheapest stocks in our Stock Screeners is:

Co-Diagnostics Inc (NASDAQ: CODX)

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI’s low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company’s diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

A quick look at the share price history for Co-Diagnostics Inc (below) over the past twelve months shows that the price is down 16%. Here’s why the company remains undervalued.

Summary

Market Cap: $263 Million

Enterprise Value: $190 Million

Operating Earnings

Operating Earnings: $50 Million

Acquirer’s Multiple

Acquirer’s Multiple: 3.79

Free Cash Flow (TTM)

Free Cash Flow: $55 Million

FCF/EV Yield

FCF/EV Yield: 29%

Other Indicators

Piotroski F-Score: 5

Altman Z-Score: 34.64

Beneish M-Score: -2.81

Shareholder Yield

Shareholder Yield: 27%

For all the latest news and podcasts, join our free newsletter here.

FREE Stock Screener

Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple:

unlimited

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.